首页> 外文期刊>Antimicrobial agents and chemotherapy. >Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.
【24h】

Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.

机译:西班牙产生抗氨苄青霉素的非β-内酰胺酶的嗜血嗜血杆菌:最近出现的克隆分离株对头孢噻肟和头孢克肟的耐药性增强。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The sequence of the ftsI gene encoding the transpeptidase domain of penicillin-binding protein 3 (PBP 3) was determined for 354 nonconsecutive Haemophilus influenzae isolates from Spain; 17.8% of them were ampicillin susceptible, 56% were beta-lactamase nonproducing ampicillin resistant (BLNAR), 15.8% were beta-lactamase producers and ampicillin resistant, and 10.4% displayed both resistance mechanisms. The ftsI gene sequences had 28 different mutation patterns and amino acid substitutions at 23 positions. Some 93.2% of the BLNAR strains had amino acid substitutions at the Lys-Thr-Gly (KTG) motif, the two most common being Asn526 to Lys (83.9%) and Arg517 to His (9.3%). Amino acid substitutions at positions 377, 385, and 389, which conferred cefotaxime and cefixime MICs 10 to 60 times higher than those of susceptible strains, were found for the first time in Europe. In 72 isolates for which the repressor acrR gene of the AcrAB efflux pump was sequenced, numerous amino acid substitutions were found. Eight isolates with ampicillin MICs of 0.25 to 2 microg/ml showed changes that predicted the early termination of the acrR reading frame. Pulsed-field gel electrophoresis analysis demonstrated that most BLNAR strains were genetically diverse, although clonal dissemination was detected in a group of isolates presenting with increased resistance to cefotaxime and cefixime. Background antibiotic use at the community level revealed a marked trend toward increased amoxicillin-clavulanic acid consumption. BLNAR H. influenzae strains have arisen by vertical and horizontal spread and have evolved to adapt rapidly to the increased selective pressures posed by the use of oral penicillins and cephalosporins.
机译:确定了来自西班牙的354例非连续性流感嗜血杆菌分离株的ftsI基因编码青霉素结合蛋白3(PBP 3)转肽酶结构域的序列。其中17.8%的人易受氨苄青霉素的侵害,56%的人不产生β-内酰胺酶的氨苄西林耐药(BLNAR),15.8%的人产生β-内酰胺酶和氨苄青霉素具有耐药性,10.4%的人同时表现出两种耐药机制。 ftsI基因序列在23个位置具有28个不同的突变模式和氨基酸取代。大约93.2%的BLNAR菌株在Lys-Thr-Gly(KTG)基序上具有氨基酸取代,最常见的两个是Asn526取代Lys(83.9%)和Arg517取代His(9.3%)。在欧洲首次发现了第377、385和389位的氨基酸取代,赋予头孢噻肟和头孢克肟的MIC比敏感菌株的MIC高10至60倍。在对AcrAB外排泵的阻遏物acrR基因进行测序的72个分离物中,发现了许多氨基酸取代。氨苄青霉素MIC为0.25至2 microg / ml的8个分离株显示出可预测acrR阅读框提前终止的变化。脉冲场凝胶电泳分析表明,大多数BLNAR菌株具有遗传多样性,尽管在一组对头孢噻肟和头孢克肟耐药性增强的分离株中检测到了克隆传播。在社区一级使用背景抗生素显示出阿莫西林-克拉维酸消耗量增加的明显趋势。 BLNAR流感嗜血杆菌菌株已经通过垂直和水平传播而出现,并且已经进化为能够迅速适应因使用口服青霉素和头孢菌素而引起的选择性压力增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号